NEW HOPE AGAINST RESISTANT BREAST CANCER: Ixabepilone, a compound being investigated by Bristol - Myers Squibb, shows some encouraging effectiveness against metastatic breast cancers that are resistant to three other
standard chemotherapy drugs (anthracycline, taxane and capecitabine).
This makes the starter materials for synthesizing the complex far more economical than a number of industry -
standard chemotherapy drugs based on platinum.
Das explained that since the compounds they've developed make cancer cells more sensitive to attack, they also remove resistance to
standard chemotherapy drugs — a serious problem in current therapies.
To study nanodiamonds» usefulness for cancer treatment, Ho's group attached them to doxorubicin,
a standard chemotherapy drug, and injected them into mice with drug - resistant breast and liver cancer.
Not exact matches
The company said a late - stage trial of its cancer
drug Abraxane met its main goal of improving the patient's time of survival without worsening skin cancer, when compared to
standard chemotherapy.
Paclitaxel and another
chemotherapy drug, carboplatin, are considered
standard, first - line treatments for advanced ovarian cancer, experts say, and most patients respond to the
drugs initially.
The experimental
drug nintedanib, combined with
standard chemotherapy with paclitaxel, causes a total remission of tumours in 50 % of patients suffering from early HER - 2 - negative breast cancer, the most common type of breast cancer.
In a head - to - head clinical trial comparing
standard chemotherapy with the immunotherapy
drug nivolumab, researchers found that people with squamous - non-small cell lung cancer who received nivolumab lived, on average, 3.2 months longer than those receiving
chemotherapy.
«In the 20 years that I've been in practice, I consider this a major milestone,» she adds, noting that the trial results helped achieve U.S. Food and
Drug Administration approval in March to treat such patients whose lung cancer progressed, despite
standard chemotherapy.
The combination of
drugs appeared less toxic than
standard chemotherapy, were relatively inexpensive and should be clinically evaluated, said Dwayne G. Stupack, PhD, the study's senior author and associate professor in the dDivision of Gynecologic Oncology at Moores Cancer Center.
The researchers then used a combination of existing United States Food and
Drug Administration - approved
drugs to target autophagy and found ovarian cancer cells to be highly sensitive to these
drugs in several different mouse cancer models — even among cells resistant to
standard chemotherapy.
«In pancreatic, ovarian and liver cancers, we hope that by adding anti-cancer stem cell
drugs to
standard of care, we can control proliferating cells within the tumor that could otherwise help the tumor regenerate in the face of existing
chemotherapies.»
When he and his colleagues gave the mice the
standard, maximum tolerated dose of the
chemotherapy drug paclitaxel, the tumours roared back as soon as the treatment was stopped.
If it would be possible to identify tumours that have an aberrantly stabilised SOX9 protein, the
drugs tested in this study could be used to prevent tumour spread in these patients and improve their response to
standard chemotherapy.
Exploiting the same pre-clinical model used for their studies, the researchers are testing the efficacy of this kind of
drug candidates against cancer stem cells, and the possibility of identifying combination regimens with
standard chemotherapies with minimized toxic effects, with the perspective of their possible application for the treatment of human breast cancer.
In addition, TGen laboratory research also found that PPF increases the effectiveness of a
standard - of - care
chemotherapy drug called temozolomide (TMZ), and radiation, to treat glioblastoma.
In elderly cancer patients like my father and aunt, who suffer from a variety of chronic health problems, physicians often modify
standard treatment regimens — perhaps using two
chemotherapy drugs instead of three or lowering
standard dosages — in the hope that the revised treatment will work well enough.
In this study, researchers compared the effectiveness of the immunotherapy
drug nivolumab (pronounced «nye VOL ue mab,» marketed at Opdivo), with
standard - of - care
chemotherapy in 541 patients with previously untreated or recurrent non-small cell lung cancer (NSCLC) that expressed PDL - 1 antibodies.
In phase 3 trials for adults with high - risk, secondary AML, there was a statistically significant improvement in overall survival compared to patients who received a regimen using
chemotherapy drugs delivered in the
standard way.
For patients with cervical cancer that has recurred after treatment or has spread elsewhere in the body, adding the experimental
drug cediranib to
standard chemotherapy improves tumour shrinkage and adds a modest improvement in progression - free survival, researchers report at the ESMO 2014 Congress in Madrid.
«Women with ovarian cancer gain extra months with addition of
drug to
standard chemotherapy.»
The trials for
chemotherapy side effects — 4 of which were randomized controlled trials — found that medical cannabis was significantly better than anti-nausea
drugs standard at the time of study for reducing nausea and vomiting.
Albeit still limited in efficacy, angiogenesis - inhibiting
drugs have become part of
standard tumor therapy supporting the efficacy of established
chemotherapies.
Researchers have found that people with advanced head and neck squamous cell carcinoma and the KRAS - variant inherited genetic mutation have significantly improved survival when given a short course of the
drug cetuximab in combination with
standard chemotherapy and radiation.
Many
standard cancer treatments, including
chemotherapy drugs and radiation therapy, damage the DNA of rapidly dividing cancer cells.
As we reported from the conference, the olympiAD trial showed that an ovarian cancer
drug can hold some advanced breast cancers at bay longer than
standard chemotherapy.
«These studies suggest the potential for dramatically reducing the dose of
chemotherapy or radiation and thereby reducing the side effects of
standard chemotherapy by enhancing the targeting of cancer therapies using HIV receptor blocking
drugs.»
«Unlike
standard chemotherapy, HIV - receptor blocking
drugs have been proven to be safe and with rare side effects,» said Richard G. Pestell, MD, PhD, MBA, President of the Pennsylvania Cancer and Regenerative Medicine Research Center (PCARMRC).
The trial involves combining
standard chemotherapy with a
drug that has been found in laboratory studies to attack cancer stem cells.
Packed with practical suggestions, nutritional advice,... View Details Physicians» Cancer
Chemotherapy Drug Manual 2018 by Edward Chu (Author), Vincent T. DeVita Jr. (Author) Completely revised and updated for 2018, the Physicians» Cancer
Chemotherapy Drug Manual is an up - to - date guide to the latest information on
standard therapy and recent advances in the field.
If it would be possible to identify tumors that have an aberrantly stabilized SOX9 protein, caused by inactivation of FBW7, the
drugs tested in this study could be used to prevent tumor spread in these patients and improve their response to
standard chemotherapy.
But these epigenetic
drugs have shown some success in improving patients» response to
chemotherapy or immunotherapy, or in overcoming resistance to those
standard treatments.
Patients with non-small cell lung cancer (NSCLC) often respond to
standard chemotherapy, only to develop
drug resistance later, and with fatal consequences.
The international early Phase II trial led by a team based at the Oxford Cancer Research Centre will trial the experimental
drug called LY2181308 with advanced non-small cell lung cancer patients who no longer respond to platinum
chemotherapy - the
standard initial treatment for this group.
Each patient will receive gemcitabine and nab - paclitaxel, two
chemotherapy drugs that are
standard of care.
Three
chemotherapy drugs and a stem - cell transplant — a regimen that far outstripped the
standard of care — briefly cured her.
A
standard treatment for prostate cancer,
chemotherapy uses
drugs to inhibit the growth of cancer cells.
This
drug is ideally used with
standard chemotherapy regimens.